Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
EqpwsXaCNcwng5Rw
